financetom
Market
financetom
/
Market
/
Hero MotoCorp’s profit dips but realisation drives revenue growth — Street cautious
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hero MotoCorp’s profit dips but realisation drives revenue growth — Street cautious
Nov 4, 2022 5:05 AM

Hero MotoCorp’s revenue grew but net profit slipped for the July to September quarter due to increased expenses and a slight dip in sales, following which investors on Dalal Street turned cautious on the two-wheeler maker’s stock on Friday.

Hero Moto’s shares declined more than 2 percent intraday on BSE even as analysts have given it a ‘buy’ rating.’

Brokerage firm Jefferies has set a target price of Rs 3,000 per share on the stock, noting that the company’s EBITDA for the second quarter of the fiscal fell 3 percent annually but was in line with estimates. The two-wheeler maker’s gross profit per vehicle and EBITDA per vehicle has gone up 7-8 percent sequentially, it pointed out.

Motilal Oswal too has a ‘buy’ call on Hero Moto’s stock saying the two-wheeler’s revenue grew 7 percent year-on-year despite flat volume growth. It said the higher realisation of 8 percent YoY drove the revenue growth.

Even as the company’s gross margin expanded to 28 percent owing to stable commodity costs and price hikes, it was still lower-than-estimated gross margin, leading to EBITDA margins declining 120bp YoY to 11.4 percent.

Niranjan Gupta, CFO Hero MotoCorp, said, “ The global macro headwinds may keep the playfield a bit uncertain, and navigating the same over the next few quarters will be important. However, as the commodities cool off, and the rate cycle reaches its peak, the medium-term outlook for the Indian auto industry appears quite encouraging.”

Also Read | Gogoro aims to remove range anxiety as riders can go up to 100 kms with our tech: Founder

He added that consumer confidence is coming back, which augurs well for growth momentum moving forward. According to Gupta, the results reflect financial discipline, focus on cost savings, capital allocation as well as premiumisation of portfolio.

Catch latest stock market updates on CNBCTV18.com's blog here

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved